The Veteran's tinea versicolor of the bilateral lower extremities has been rated at 10 percent since July 2022. The Board found that the condition does not meet criteria for a higher rating as it did not cover more than 20% of his total body area or require systemic therapy.
The deciding factor: The Veteran's tinea versicolor covered less than 20% of his total body area and did not require any systemic therapy, which is necessary to warrant a higher rating under the applicable diagnostic code.
- Claimed conditions
- tinea versicolor
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- October 18, 2022
- Citation
- A22020994
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A22020994.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board is remanding the claim for tinea versicolor to ensure that VA fulfills its duty to assist by obtaining private medical records and potentially scheduling a new examination.
- Granted
The Board granted service connection for enlarged liver (fatty infiltration), benign prostate hypertrophy, and tinea versicolor as secondary to the Veteran's service-connected diabetes mellitus, type II.
- Partly granted
The Board granted readjudication for the claims of service connection for left foot hallux valgus and tinea versicolor, but denied the claims for tinea corporis, tinea cruris, carbuncle, cyst, and scarring secondary to tinea versicolor.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.